Large-scale testing (Phase 3)Active Not RecruitingNCT04889430
What this trial is testing
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 34